Raymond James & Associates’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$5.56M Buy
76,232
+11,288
+17% +$833K ﹤0.01% 1591
2024
Q2
$4.35M Buy
64,944
+2,943
+5% +$114K ﹤0.01% 1681
2024
Q1
$1.68M Buy
62,001
+20,885
+51% +$584K ﹤0.01% 2271
2023
Q4
$1.27M Sell
41,116
-3,098
-7% -$80.3K ﹤0.01% 2375
2023
Q3
$1.12M Buy
44,214
+12,573
+40% +$288K ﹤0.01% 2387
2023
Q2
$668K Sell
31,641
-692
-2% -$13.1K ﹤0.01% 2741
2023
Q1
$551K Buy
32,333
+4,542
+16% +$88.2K ﹤0.01% 2861
2022
Q4
$555K Buy
27,791
+6,131
+28% +$119K ﹤0.01% 2826
2022
Q3
$467K Buy
21,660
+850
+4% +$20.4K ﹤0.01% 2910
2022
Q2
$410K Sell
20,810
-77
-0.4% -$1.61K ﹤0.01% 3032
2022
Q1
$491K Sell
20,887
-284
-1% -$6.6K ﹤0.01% 3088
2021
Q4
$577K Sell
21,171
-791
-4% -$22.6K ﹤0.01% 2983
2021
Q3
$605K Sell
21,962
-1,072
-5% -$28.1K ﹤0.01% 2925
2021
Q2
$656K Buy
23,034
+742
+3% +$22K ﹤0.01% 2885
2021
Q1
$759K Sell
22,292
-576
-3% -$22K ﹤0.01% 2697
2020
Q4
$761K Sell
22,868
-651
-3% -$23.8K ﹤0.01% 2523
2020
Q3
$756K Buy
23,519
+519
+2% +$14.9K ﹤0.01% 2349
2020
Q2
$633K Buy
23,000
+5,869
+34% +$139K ﹤0.01% 2442
2020
Q1
$275K Sell
17,131
-178,518
-91% -$4.23M ﹤0.01% 2829
2019
Q4
$4.67M Buy
195,649
+18,419
+10% +$375K 0.01% 1296
2019
Q3
$3.13M Buy
177,230
+34,933
+25% +$675K ﹤0.01% 1522
2019
Q2
$3.64M Buy
142,297
+39,976
+39% +$1.11M 0.01% 1423
2019
Q1
$2.97M Buy
102,321
+44,564
+77% +$1.15M ﹤0.01% 1514
2018
Q4
$758K Buy
57,757
+29,150
+102% +$465K ﹤0.01% 2258
2018
Q3
$578K Buy
+28,607
New +$646K ﹤0.01% 2612

Other funds holding INSM